Loading viewer...
earnings
Format: PDF earnings
Moderna presented first quarter 2024 financial results and business update on May 2, 2024, including RSV vaccine commercialization plans, 2024 financial guidance, and pipeline milestones. The earnings presentation outlined anticipated product sales, competitive positioning, and clinical development progress for multiple mRNA programs.
earnings
36 Pages
ENGIE
Tyson Foods 1Q 2023 Earnings Presentation
earningsearnings
26 Pages
Tyson Foods, Inc.